Systemic Antibiotic Prophylaxis Adjunctive to Surgical Reconstructive Peri‐Implantitis Treatment: A Retrospective Study
Clinical Implant Dentistry and Related Research · 2025
DOI: 10.1111/cid.13429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Implant Dentistry and Related Research, 2025. Verfasst von Ausra Ramanauskaite und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Surgery and Implantology, Goethe-University Frankfurt, Carolinum, Frankfurt, Germany. Hauptthemen laut MEDLINE: Peri-Implantitis, Antibiotic Prophylaxis, Anti-Bacterial Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
To evaluate the clinical efficacy of oral systemic antibiotic prophylaxis administered along with the surgical reconstructive peri‐implantitis treatment.
Methods
A total of 49 patients exhibiting 70 implants diagnosed with peri‐implantitis underwent a surgical reconstructive peri‐implantitis treatment. Of them, 27 patients (38 implants) received a single preoperative shot of antibiotics (2 g amoxicillin; Pre‐op), 12 patients (19 implants) were prescribed with postoperative antibiotics for 3 days (500 mg amoxicillin, 3 x day, Post‐op), and the remaining 10 patients (13 implants) did not receive any systemic antibiotics (No‐Ab). Mean probing depth values (mean PDs; primary outcome), bleeding on probing (BOP), plaque (PI), suppuration (Sup), and deepest PDs values (max PD) were assessed prior to surgery (baseline), after 6 and 12 months. To assess the differences in changes in the clinical parameters, and disease resolution (PD ≤ 5 mm, ≤ 1 BOP site and no Sup) among the groups, logistic regression analyses were performed.
Results
After 12 months, the mean PD reduction amounted to −1.74 ± 1.56 mm, −1.91 ± 1.88 mm, and −1.13 ± 1.05 mm in the No‐Ab, Pre‐op, and Post‐op groups, respectively, with no significant difference detected among the groups. The BOP was reduced in 60%, 59.3%, and 83.3% of the patients after 12 months in the No‐Ab, Pre‐op, and Post‐op groups, respectively, with no significant differences among them. The PI, Sup and max PD reductions were comparable among the groups. Disease resolution after 12 months was established in 61.5%, 73.7%, and 89.5% of patients in the No‐Ab, Pre‐op, and Post‐op groups (No‐Ab vs. Pre‐op: p = 0.10, No‐Ab vs. Post‐op: p = 0.40, Pre‐op vs. Post‐op: p = 0.84).
Conclusion
Systemic antibiotic prophylaxis did not improve the clinical outcomes of surgical reconstructive peri‐implantitis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Surgery and Implantology, Goethe-University Frankfurt, Carolinum, Frankfurt, Germany.
- Faculty of Medicine, Institute of Biostatistics and Mathematical Modelling, Goethe University, Frankfurt am Main, Germany.
ORCID-Profile: Karina Obreja, Frank Schwarz
Zitieren
APA
Ramanauskaite, A., Saltzer, I., Padhye, N., Begic, A., Obreja, K., Dahmer, I., & Schwarz, F. (2025). Systemic Antibiotic Prophylaxis Adjunctive to Surgical Reconstructive Peri‐Implantitis Treatment: A Retrospective Study. Clinical Implant Dentistry and Related Research. https://doi.org/10.1111/cid.13429
Vancouver
Ramanauskaite A, Saltzer I, Padhye N, Begic A, Obreja K, Dahmer I, et al. Systemic Antibiotic Prophylaxis Adjunctive to Surgical Reconstructive Peri‐Implantitis Treatment: A Retrospective Study. Clinical Implant Dentistry and Related Research. 2025. doi:10.1111/cid.13429
BibTeX
@article{Ramanauskaite2025,
author = {Ramanauskaite, Ausra and Saltzer, Ioanna and Padhye, Ninad and Begic, Amira and Obreja, Karina and Dahmer, Iulia and Schwarz, Frank},
title = {Systemic Antibiotic Prophylaxis Adjunctive to Surgical Reconstructive Peri‐Implantitis Treatment: A Retrospective Study},
journal = {Clinical Implant Dentistry and Related Research},
year = {2025},
doi = {10.1111/cid.13429}
}
EUVIMED